Ubs Group Ag Bicycle Therapeutics PLC Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Ubs Group Ag holds 12,066 shares of BCYC stock, worth $156,616. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,066

Previous 15,935 24.28%

Holding current value

$156,616

Previous $322,000 15.22%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.58 - $27.24 $75,755 - $105,391	-3,869 Reduced 24.28%	12,066 $273,000
Q2 2024 Aug 13, 2024	BUY	$20.02 - $24.69 $119,179 - $146,979	5,953 Added 59.64%	15,935 $322,000
Q1 2024 May 13, 2024	SELL	$16.75 - $26.1 $19,564 - $30,484	-1,168 Reduced 10.48%	9,982 $248,000
Q4 2023 Feb 09, 2024	SELL	$13.29 - $22.2 $2,059 - $3,441	-155 Reduced 1.37%	11,150 $201,000
Q3 2023 Nov 09, 2023	SELL	$19.9 - $26.25 $26,009 - $34,308	-1,307 Reduced 10.36%	11,305 $227,000
Q2 2023 Aug 11, 2023	SELL	$18.95 - $28.67 $24,256 - $36,697	-1,280 Reduced 9.21%	12,612 $321,000
Q1 2023 May 12, 2023	BUY	$20.02 - $31.37 $19,019 - $29,801	950 Added 7.34%	13,892 $295,000
Q4 2022 Feb 08, 2023	SELL	$20.37 - $32.9 $316,407 - $511,035	-15,533 Reduced 54.55%	12,942 $383,000
Q3 2022 Nov 10, 2022	BUY	$17.49 - $28.44 $271,252 - $441,075	15,509 Added 119.61%	28,475 $662,000
Q2 2022 Aug 10, 2022	BUY	$12.95 - $46.99 $52,861 - $191,813	4,082 Added 45.95%	12,966 $218,000
Q1 2022 May 16, 2022	BUY	$40.12 - $59.5 $320,639 - $475,524	7,992 Added 895.96%	8,884 $389,000
Q4 2021 Feb 14, 2022	BUY	$41.7 - $61.14 $1,918 - $2,812	46 Added 5.44%	892 $54,000
Q3 2021 Nov 15, 2021	SELL	$27.95 - $44.24 $24,288 - $38,444	-869 Reduced 50.67%	846 $35,000
Q2 2021 Aug 13, 2021	BUY	$27.0 - $32.28 $36,801 - $43,997	1,363 Added 387.22%	1,715 $52,000
Q1 2021 May 12, 2021	BUY	$19.12 - $30.25 $2,256 - $3,569	118 Added 50.43%	352 $11,000
Q4 2020 Feb 11, 2021	SELL	$17.95 - $21.36 $4,684 - $5,574	-261 Reduced 52.73%	234 $4,000
Q3 2020 Nov 12, 2020	SELL	$15.3 - $20.8 $27,387 - $37,232	-1,790 Reduced 78.34%	495 $9,000
Q2 2020 Jul 31, 2020	BUY	$12.63 - $18.21 $28,859 - $41,609	2,285 New	2,285 $36,000
Q3 2019 Nov 14, 2019	SELL	$6.74 - $12.01 $11,579 - $20,633	-1,718 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.06 - $14.63 $17,283 - $25,134	1,718 New	1,718 $17,000

Others Institutions Holding BCYC

# of Institutions

113

Shares Held

40.8M

Call Options Held

39.6K

Put Options Held

24.6K

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $385M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account